A comparison of albuterol and metaproterenol nebulizer solutions

M. P. Habib, S. C. Campbell, B. Y. Shon, J. L. Pinnas

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

Metaproterenol (15 mg) and albuterol (5 mg) solutions were each nebulized and delivered to 20 patients with reversible airway obstruction utilizing intermittent positive pressure ventilation in a double-blind comparison. Ten subjects were randomly assigned to each group and they were examined at the start (day 0) and at the end of the study (day 7). There were no significant differences observed between the spirometric responses or the untoward effects of the two groups to either agent. Albuterol and metaproterenol, when administered by intermittent positive pressure ventilation, are essentially equivalent in terms of the magnitude and duration of the response.

Original languageEnglish (US)
Pages (from-to)421-424
Number of pages4
JournalAnnals of Allergy
Volume58
Issue number6
StatePublished - Jan 1 1987

ASJC Scopus subject areas

  • Immunology and Allergy

Fingerprint Dive into the research topics of 'A comparison of albuterol and metaproterenol nebulizer solutions'. Together they form a unique fingerprint.

  • Cite this

    Habib, M. P., Campbell, S. C., Shon, B. Y., & Pinnas, J. L. (1987). A comparison of albuterol and metaproterenol nebulizer solutions. Annals of Allergy, 58(6), 421-424.